Established in 2007, this family-owned manufacturer specializes in pharmaceutical formulations, offering over 500 products across various dosage forms, including tablets, capsules, dry syrups, ointments, dry injections, and liquid orals. As a CTD dossier owner and manufacturer, it holds WHO-cGMP certification, ensuring compliance with stringent international quality standards. The manufacturer operates advanced production lines with capacities such as 3,600 million tablets, 1,800 million capsules, 240 million liquid injections in ampoules, and 70 million dry powder injections per annum, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

This CTD dossier owner and manufacturer company is a WHO-GMP certified manufacturer and exporter focused on producing a wide range of formulations including beta-lactam products, effervescents, injections, eye/ear/nasal drops, ointments, veterinary medications, hormones, and food supplements. They target key regions in the Middle East, Africa, and Asia with an emphasis on brand building in export markets. The company holds multiple awards for its product quality and export excellence. Their commitment to quality is reflected in their ISO 9001:2008 certification and they prioritize ethical decision-making and transparency. The broad range of products suggests a focus on both acute and chronic conditions.

This CTD dossier owner and manufacturer is a technology-driven enterprise with a focus on product quality and timely delivery. Its ultra-modern, WHO and GMP-certified manufacturing facility is located in a pollution-free industrial estate near major SEZ hubs in Asia. The company exports its products to Southeast Asia, Africa, the CIS region, Latin America & Central America, and the GCC. They supply prescription medications and likely over-the-counter drugs, as indicated by their global distribution network. They emphasize a "human approach" to business with trade partners and prioritize ethical production practices.